Follow
jean-louis beaudeux
jean-louis beaudeux
Faculté de Pharmacie de Paris
Verified email at parisdescartes.fr
Title
Cited by
Cited by
Year
Resveratrol bioavailability and toxicity in humans
CH Cottart, V Nivet‐Antoine, C Laguillier‐Morizot, JL Beaudeux
Molecular nutrition & food research 54 (1), 7-16, 2010
6492010
Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
JL Beaudeux, P Giral, E Bruckert, MJ Foglietti, MJ Chapman
Clinical Chemistry and Laboratory Medicine (CCLM) 42 (2), 121-131, 2004
2972004
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans
CH Cottart, V Nivet‐Antoine, JL Beaudeux
Molecular nutrition & food research 58 (1), 7-21, 2014
2802014
Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells
N Ouslimani, J Peynet, D Bonnefont-Rousselot, P Thérond, A Legrand, ...
Metabolism 54 (6), 829-834, 2005
2652005
S100-B protein as a screening tool for the early assessment of minor head injury
D Zongo, R Ribéreau-Gayon, F Masson, M Laborey, B Contrand, ...
Annals of emergency medicine 59 (3), 209-218, 2012
2092012
Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions
L Camont, CH Cottart, Y Rhayem, V Nivet-Antoine, R Djelidi, F Collin, ...
Analytica chimica acta 634 (1), 121-128, 2009
1882009
Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk
JL Beaudeux, L Burc, F Imbert-Bismut, P Giral, M Bernard, E Bruckert, ...
Arteriosclerosis, thrombosis, and vascular biology 23 (1), e7-e10, 2003
1882003
Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage
N Weiss, P Sanchez-Pena, S Roche, JL Beaudeux, C Colonne, P Coriat, ...
The Journal of the American Society of Anesthesiologists 104 (4), 658-666, 2006
1262006
Radicaux libres et stress oxydant: aspects biologiques et pathologiques
J Delattre, JL Beaudeux, D Bonnefont-Rousselot
Editions Tec & Doc, 2005
1242005
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia
JL Beaudeux, P Giral, E Bruckert, M Bernard, MJ Foglietti, MJ Chapman
Atherosclerosis 169 (1), 139-146, 2003
1222003
Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy
S Jacqueminet, OB Abdesselam, MJ Chapman, N Nicolay, MJ Foglietti, ...
Clinica chimica acta 367 (1-2), 103-107, 2006
1052006
Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes
M Challier, S Jacqueminet, O Benabdesselam, A Grimaldi, JL Beaudeux
Clinical Chemistry 51 (9), 1749-1750, 2005
1002005
High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis
D Bonnefont-Rousselot, P Thérond, JL Beaudeux, J Peynet, A Le-grand, ...
Walter de Gruyter 37 (10), 939-948, 1999
971999
Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1
N Ouslimani, M Mahrouf, J Peynet, D Bonnefont-Rousselot, C Cosson, ...
Metabolism 56 (3), 308-313, 2007
962007
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes
F Ganné, M Vasse, JL Beaudeux, J Peynet, A François, Z Mishal, ...
Thrombosis and haemostasis 84 (10), 680-688, 2000
932000
Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C
M Mahrouf, N Ouslimani, J Peynet, R Djelidi, M Couturier, P Therond, ...
Biochemical pharmacology 72 (2), 176-183, 2006
912006
Influence of hemolysis on the measurement of S-100β protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting
JL Beaudeux, P Leger, L Dequen, I Gandjbakhch, P Coriat, MJ Foglietti
Clinical chemistry 46 (7), 989-990, 2000
882000
Diabetes mellitus, oxidative stress and advanced glycation endproducts
D Bonnefont-Rousselot, JL Beaudeux, P Therond, J Peynet, A Legrand, ...
Annales Pharmaceutiques Francaises 62 (3), 147-157, 2004
872004
Reference values for serum S-100B protein depend on the race of individuals
O Ben Abdesselam, J Vally, C Adem, MJ Foglietti, JL Beaudeux
Clinical chemistry 49 (5), 836-837, 2003
862003
Cytoprotective effect against UV-induced DNA damage and oxidative stress: role of new biological UV filter
T Said, M Dutot, C Martin, JL Beaudeux, C Boucher, E Enee, C Baudouin, ...
European Journal of Pharmaceutical Sciences 30 (3-4), 203-210, 2007
802007
The system can't perform the operation now. Try again later.
Articles 1–20